期刊文献+

光刺激对痴呆小鼠海马长时程增强及β淀粉样蛋白含量的影响 被引量:2

Effect of Photic Stimulation on Long Term Potentiation and A beta Content in Hippocampus of Dementia Mice
在线阅读 下载PDF
导出
摘要 目的:观察光刺激对3x Tg阿尔茨海默病(AD)模型小鼠海马长时程增强(LTP)及β淀粉样蛋白(Aβ)的影响。方法:4~6月3x Tg AD小鼠20只随机分为光刺激(PS)组,未刺激(NS)组,同背景野生型小鼠10只为对照组。PS组小鼠接受2 Hz光刺激4周,其余2组正常环境饲养。4周后断头取脑,制作离体脑片,诱导海马LTP,并检测小鼠海马组织内Aβ蛋白含量。结果:NS组小鼠LTP明显受抑,海马组织内Aβ含量较对照组明显升高(P<0.05)。PS组小鼠较NS组小鼠海马Aβ蛋白水平明显降低(P<0.05),LTP明显增强(P<0.05)。结论:光刺激增强3x Tg AD模型小鼠海马LTP,降低海马Aβ含量。 Objective: To observe the effect ofphotic stimulation on long term potentiation (LTP) and A beta in the hippocampus of 3xTg Alzheimer's model mice. Methods: Twenty 4 - 6 month 3xTg AD mice were random- ly divided into photic stimulation (PS) group and unstimulated (NS) group. Ten wild type mice in the same back- ground were in the control group. AD mice in the PS group received 2 Hz photic stimulation for 4 weeks. After the mice were decapitated, the in vitro hippocampal LTP was induced and the A beta protein content in the hippo- campus of mice was detected. Results: The LTP of mice in NS group was significantly inhibited, and the content of A beta in the hippocampus was significantly higher than that in control group (both P〈0.05). The level of A beta protein in hippocampus of mice in PS group was significantly lower than that in NS group, while LTP in- creased significantly (both P〈0.05). Conclusion: Photic stimulation enhanced the hippocampal LTP and reduced the content of A beta in 3xTg AD mice model.
出处 《神经损伤与功能重建》 2018年第2期55-56,61,共3页 Neural Injury and Functional Reconstruction
基金 国家自然科学基金(No.81671064 No.81371222) 日本文部科学省科学研究费补助金(No.22500360)
关键词 阿尔茨海默病 光刺激 长时程增强 Β淀粉样蛋白 Alzheimer's Disease photic stimulation long term potentiation β-amyloid protein
作者简介 通讯作者:王芙蓉wangfurong.china@163.com
  • 相关文献

参考文献2

二级参考文献52

  • 1陈新平,陈彪.阿尔茨海默病病因学及发病机制研究进展[J].中国现代神经疾病杂志,2005,5(3):152-155. 被引量:28
  • 2刘英华,王建枝.tau蛋白异常与阿尔茨海默病的关系[J].生命的化学,2006,26(2):108-110. 被引量:8
  • 3Hellstrom-Lindahl E,Viitaen M,Marufle A. Comparison of Aβ levels in the brain of familial and sporadic Alzheimer' s disease[J]. Neurochem Inter, 2009,55:243-252.
  • 4Nelson PT,Braak H,Markesbery WR. Neuropathology and cognitive impair ment in Alzheimer disease:a complex but coherent relationship[J]. J Neuropath & Exp Neurol,2009,68(1) :1-14.
  • 5Qiu C,Kivipelto M, Von Strauss E. Epidemiology of Alzheimer' s disease:occurrence,determinants,and strategies toward intervention [ J ]. Dialog in Clin Neurosci ,2009,11(2) :111-128.
  • 6Tebbenkamp AT,Borchelt DR. Protein aggregate characterization in models of neurodegenerative disease[ J]. Meth Mole Biol,2009,566:85-91.
  • 7Wang YJ,Zhou HD,Zhou XF. Clearance of amyloid-beta in Alzheimer' s disease:progress,problems and perspectives[ J ]. Drug Discovery Today, 2006,11(19/20) :931-938.
  • 8Stein TD,Anders NJ ,Decarli C,et al, Neutralization of tmnsthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSW mice resulting in tan phosphorylation and loss of hippocampal neuions:support for the amyloid hypothesis [ J ]. Neurobio Dis,2004,24( 35 ) : 7707-7717.
  • 9Kaether C,Haass C,Steiner H. Assembly,trafficking and function of γ-secretase[J]. Neurodege Dis ,2006,3 :275-283.
  • 10Prokop S,Shirotani K,Edbauer D,et al. Requirement of PEN-2 for stabilization of the presenilin N-/C-terminal fragment heterodimer within the γ- secretase complex[J]. J Biol Chem,2004,279(22) :23255-23261.

共引文献85

同被引文献14

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部